Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-Q, Date: 2010-08-09
Original SEC Filing: Click here

---

Webplus: CPHI/20100809/10-Q_1/1/000.htm SEC Original: cphi10q063010.htm
FORM 10-Q (Mark One) x June 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer’s telephone number, including area code)

---

---

Webplus: CPHI/20100809/10-Q_1/2_EX-3.1/000.htm SEC Original: cphi10qex31063010.htm
EX-3.1 2 cphi10qex31063010.htm AMENDED AND RESTATED CHARTER

---

---

Webplus: CPHI/20100809/10-Q_1/7_EX-10.1/000.htm SEC Original: cphi10qex101063010.htm
EMPLOYMENT AGREEMENT April 28 Agreement Company nd Employee XXX XX XXXX Parties This EMPLOYMENT AGREEMENT is made and entered into as of WITNESSETH: WHEREAS, the Company is engaged in the business of develop, manufacture, and market specialty pharmaceutical products in China (the “business”); and WHEREAS, Employee has represented that he has the experience, background and expertise necessary to enable his

---

---

Webplus: CPHI/20100809/10-Q_1/8_EX-10.2/000.htm SEC Original: cphi10qex102063010.htm
CHINA PHARMA HOLDINGS, INC. 2010 SHARES OPTION AGREEMENT China Pharma Holdings, Inc., Frank Waung This 2010 Shares Option Agreement (the “Agreement”) is made as of April 28, 2010 between 1. Notice of Shares Option Grant You (the “Optionee”) have been granted an option to subscribe for, acquire and purchase common shares in the Company (the “Common Shares”), subject to the

---

---

Webplus: CPHI/20100809/10-Q_1/9_EX-31.1/000.htm SEC Original: cphi10qex311063010.htm
CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were

---

---

Webplus: CPHI/20100809/10-Q_1/10_EX-31.2/000.htm SEC Original: cphi10qex312063010.htm
CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were

---

---

Webplus: CPHI/20100809/10-Q_1/11_EX-32.1/000.htm SEC Original: cphi10qex321063010.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 9, 2010 ——————————– President and Chief Executive Officer

---

---

Webplus: CPHI/20100809/10-Q_1/12_EX-32.2/000.htm SEC Original: cpho10qex322063010.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 9, 2010 ——————— (principal financial officer and principal accounting officer)

---

Company Information:

Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-Q, Date: 2010-08-09CIK: 0001106644, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
2ND FLOOR, NO. 17, JINPAN ROAD, HAIKOU
HAINAN PROVINCE 570216